Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.

JOURNAL OF PHARMACY TECHNOLOGY is a premier publication in the field of Pharmaceutical Science, established in 1989 and published by SAGE PUBLICATIONS INC. This journal serves as an essential resource for professionals, researchers, and students dedicated to the advancements in pharmacy technology and the application of innovative solutions in pharmaceutical practices. With an ISSN of 8755-1225 and an E-ISSN of 1549-4810, the journal provides a rigorous peer-reviewed platform for disseminating cutting-edge research and case studies. As of 2023, it is ranked Q3 in the Scopus categories of Pharmacology, Toxicology, and Pharmaceutics, highlighting its relevance in the field. Although it currently does not offer an Open Access option, JOURNAL OF PHARMACY TECHNOLOGY aims to remain a critical avenue for scholarly communication and knowledge dissemination among practitioners in the pharmaceutical sector, ensuring they stay informed of the latest trends and findings that impact their work.

The Canadian Pharmacists Journal, published by SAGE Publications Inc, serves as a pivotal platform for advancing research and dialogue within the fields of Pharmaceutical Science and Pharmacy. With an ISSN of 1715-1635 and an E-ISSN of 1913-701X, this esteemed journal has demonstrated its commitment to excellence, securing a notable Q2 ranking in both categories as of 2023. Researchers and practitioners can access a wealth of knowledge from its publications, reflecting innovative practices and foundational studies in the realm of pharmacy. The journal's scope is expansive, targeting key issues that drive the evolution of pharmaceutical practices in Canada and beyond, making it an indispensable resource for pharmacists, healthcare professionals, and students dedicated to the advancement of patient care and medication safety. Its dedicated insights and analyses are vital for fostering a deeper understanding of the dynamic landscape of pharmacy, ensuring that it remains a crucial reference point for all stakeholders in the field.

Canadian Journal of Hospital Pharmacy, published by the Canadian Society of Hospital Pharmacists, stands as a pivotal resource within the field of pharmacy and medical pharmacology since its inception in 1973. With its ISSN 0008-4123, this peer-reviewed journal aims to advance the knowledge and practice of hospital pharmacy through the dissemination of high-quality research, reviews, and case studies. Although currently not an open-access journal, it boasts a respectable influence in the academic community, reflected in its Q3 quartile rankings in both pharmacology and pharmacy as of 2023. Located in Ottawa, Canada, the journal encourages contributions that emphasize evidence-based practices and innovative solutions to enhance patient care. By fostering a dialogue among pharmacists, researchers, and healthcare professionals, the Canadian Journal of Hospital Pharmacy continues to be an essential platform for addressing contemporary issues and advancements in the hospital pharmacy landscape.

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Research in Social & Administrative Pharmacy, published by Elsevier Science Inc, is a premier academic journal that plays a pivotal role in shaping the field of pharmaceutical sciences and pharmacy practice. With an impressive impact factor and ranked in the Q1 category for both Pharmaceutical Science and Pharmacy, this journal is dedicated to the dissemination of cutting-edge research from 2005 to 2024. Targeting a diverse audience of researchers, professionals, and students, the journal covers a broad spectrum of topics including social pharmacy, policy, and administrative aspects of pharmacy practice, contributing to advancements in healthcare. As an essential resource for those engaging in pharmaceutical research, the journal upholds rigorous peer-review standards and ensures wide accessibility to influential studies that address contemporary issues in pharmacy and healthcare administration, making it an invaluable tool for knowledge enhancement and practical applications.

INTERNATIONAL JOURNAL OF PHARMACY PRACTICE is a distinguished peer-reviewed journal published by Oxford University Press that has been serving the pharmacy and healthcare community since 1991. With the ISSN 0961-7671 and E-ISSN 2042-7174, the journal aims to advance the field of pharmacy practice through the dissemination of high-quality research and innovative practices. The journal is recognized for its impactful contributions, holding a Q1 status in Pharmacy and laying within the Q2 to Q3 quartiles across various health-related categories in 2023, underscoring its commitment to excellence. It occupies a notable position within Scopus rankings, most prominently within the Health Professions: Pharmacy category, where it ranks 12th out of 45 journals, reflecting its relevance and significance in the field. Scholars and practitioners benefit from the journal's rich repository of knowledge that encompasses diverse topics, including pharmaceutical sciences and health policy, supporting the development and enhancement of pharmacy practices worldwide. Although it is not an open-access journal, it continues to be a crucial resource for professionals and academics seeking to stay at the forefront of pharmacy practice advancements.

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.